Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

Journal for immunotherapy of cancer·2026
Same author

Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same author

Pancreatic resection for metastatic renal cell carcinoma: outcomes in the era of immunotherapy and targeted therapy.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the Bladder.

Urology·2026
Same author

Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio.

Urologic oncology·2026
Same author

Clinicopathologic, molecular, and treatment features of metastatic and distantly recurrent extramammary Paget disease: Mayo clinic experience.

The oncologist·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
查看所有相关文章

相关实验视频

Updated: Feb 28, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K

针对非肌肉侵入性膀癌的免疫疗法的最新进展

Abby L Grier1, Jeffrey Y Zhong2, Spyridon Basourakos3

  • 1School of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

Cancers
|February 27, 2026
PubMed
概括
此摘要是机器生成的。

由于复发和Bacillus Calmette-Guérin (BCG) 缺乏,非肌肉侵入性膀癌 (NMIBC) 需要新的治疗方法. 免疫疗法为BCG不响应的NMIBC提供了有希望的替代方案,改善了患者的治疗结果.

关键词:
巴西勒斯卡尔梅特-盖林菌膀癌:膀癌是一种癌症.免疫检查点抑制剂免疫检查点抑制剂免疫疗法 免疫疗法通过静脉内治疗治疗.膀癌是非肌肉侵入性的膀癌.膀瘤的通过尿道切除.

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.7K

相关实验视频

Last Updated: Feb 28, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.8K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

13.2K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.7K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.

背景情况:

  • 非肌肉侵入性膀癌 (NMIBC) 占膀癌诊断的75% .
  • 高复发率和进展率需要密集监测和治疗.
  • Calmette-Guérin (BCG) 是高风险NMIBC的标准,但存在短缺和副作用.

研究的目的:

  • 审查NMIBC的静脉内和全身免疫疗法的进展.
  • 突出正在进行的临床试验和新兴的治疗选择.
  • 讨论试验设计,测序,疗效和安全方面的争议.

主要方法:

  • 对最近的临床试验和FDA批准的免疫疗法进行叙述性审查.
  • 对BCG不响应的NMIBC治疗结果的分析.
  • 讨论激进囊切除的治疗替代方案.

主要成果:

  • 几种静脉内和全身免疫疗法已在BCG不响应的NMIBC中显示出有效性.
  • 美国食品和药物管理局批准的药物包括纳多法拉基因firadenovec,诺格潘德基因α-inbakicept和pembrolizumab.
  • 目前正在进行的试验继续扩大治疗选择,并研究新的组合.

结论:

  • 免疫疗法代表了NMIBC管理的重大进步,特别是在BCG耐药病例中.
  • 鉴于其对生活质量的影响,激进囊切除的替代方案至关重要.
  • 需要进一步的研究来优化治疗顺序和比较疗效.